High Times
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, NASDAQ2020, IB_, namtae, Chasing
Search This Board: 
Last Post: 10/20/2018 2:16:56 PM - Followers: 842 - Board type: Free - Posts Today: 13

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
\
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


High Times
ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Amended Quarterly Report (10-q/a) 10/17/2018 05:17:42 PM
ELTP News: Current Report Filing (8-k) 09/18/2018 04:18:03 PM
ELTP News: Confidential Treatment Order (ct Order) 09/06/2018 11:38:56 AM
ELTP News: Amended Current Report Filing (8-k/a) 08/30/2018 04:18:29 PM
ELTP News: Current Report Filing (8-k) 08/14/2018 01:21:34 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#302013  Sticky Note "Within 12 months, stock will be at $1 IB_ 10/17/18 06:44:01 PM
#301076  Sticky Note List of ELTP Filed Drugs with FDA meshcan 09/26/18 12:13:00 AM
#300504  Sticky Note Abuse-Deterrent Opioids: A Business Answer To The Opioid NASDAQ2020 09/17/18 09:33:36 AM
#299403  Sticky Note one thing was left out, that is the dr_lowenstein 08/30/18 11:24:33 AM
#297872  Sticky Note Transcript for August 10, 2018 Conference Call: rrr2003 08/11/18 12:23:56 AM
#274770  Sticky Note memorable "calls" for elite pharma: dr_lowenstein 10/24/17 04:09:11 PM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#302148   LoL newguy11 10/20/18 02:16:56 PM
#302146   hmmmm so what market share does elite now dr_lowenstein 10/20/18 01:48:53 PM
#302145   JJ- Nice post. Thanks. mts 10/20/18 12:51:32 PM
#302144   Theres one very important, crucial factor being overlooked namtae 10/20/18 12:28:23 PM
#302143   If theres one thing you can believe, its this namtae 10/20/18 11:09:14 AM
#302141   “Today’s The Day” Mel Fischer Jimmy Joe 10/20/18 11:00:13 AM
#302140   Get ready for another one. Moose45 10/20/18 10:59:20 AM
#302139   And unlike the site transfers that Epic was Jimmy Joe 10/20/18 10:47:39 AM
#302138   LOL, that’s exactly what I was told before NASDAQ2020 10/20/18 07:37:02 AM
#302137   TOTAL BS as USUAL! stockboy 10/20/18 03:30:08 AM
#302135   Little to No Competition for Elite’s 2019 Products NASDAQ2020 10/19/18 10:26:32 PM
#302134   Here is a taste of what’s coming: NASDAQ2020 10/19/18 10:24:35 PM
#302133   I made a ton in that pump and dr_lowenstein 10/19/18 10:17:02 PM
#302132   Lucky for me. I thx the FDA for NASDAQ2020 10/19/18 10:07:57 PM
#302131   been hearing that for 5 years, thanks but dr_lowenstein 10/19/18 09:46:54 PM
#302130   Better load up! Moose45 10/19/18 09:43:49 PM
#302129   And yet this is a 8 penny stock hmmmmmmmm dr_lowenstein 10/19/18 09:34:48 PM
#302128   Here is what $3-4 Billion gets ya: NASDAQ2020 10/19/18 09:13:58 PM
#302127   What about the other million people with PD NASDAQ2020 10/19/18 09:10:09 PM
#302126   the nonsense continues, now BP is going to dr_lowenstein 10/19/18 08:02:58 PM
#302125   wow. impressive list, who are they going to buy? dr_lowenstein 10/19/18 08:01:15 PM
#302124   IsrADIPINE'S 150K A YEAR Rx'S WON'T DO SHIT stockboy 10/19/18 06:48:15 PM
#302123   Nice find!! Mahalo nui loa for sharing!! Makai63 10/19/18 05:38:53 PM
#302122   Tanya Simuni, MD , looks like it will WeeZuhl 10/19/18 05:37:03 PM
#302121   looking through some players on the phase 3 62bluejay 10/19/18 05:23:51 PM
#302120   Lookin' good. aELmTPa 10/19/18 05:14:53 PM
#302119   I started loading at HammerBottom $0.056 earlier this year. NASDAQ2020 10/19/18 04:33:09 PM
#302118   Tax loss selling of Elite could be kicking namtae 10/19/18 04:29:01 PM
#302117   Tanya Simuni, MD , looks like it will toofun 10/19/18 04:19:59 PM
#302116   because he has no plan, that is the dr_lowenstein 10/19/18 04:18:15 PM
#302115   Nasrat Unleash The Kraken !!! NASDAQ2020 10/19/18 04:12:13 PM
#302114   Maybe the same reason the ceo held Sequest namtae 10/19/18 04:04:35 PM
#302113   Nasrat holing Isradapine close to the vest. NASDAQ2020 10/19/18 04:01:28 PM
#302112   Elite execs must be doing something right. namtae 10/19/18 04:00:30 PM
#302111   The price of Isradapine is going up !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! NASDAQ2020 10/19/18 03:58:50 PM
#302110   how? what % of the market does elite dr_lowenstein 10/19/18 03:53:27 PM
#302109   Nasrat poised to take 40-50 % of Isradapine market. NASDAQ2020 10/19/18 03:31:14 PM
#302108   If theres any way to make $$ off namtae 10/19/18 03:19:03 PM
#302107   Total BS nasrat had no idea about isradipine dr_lowenstein 10/19/18 03:13:03 PM
#302106   Thanks for the response. I forgot that Nas imanjen13 10/19/18 03:06:16 PM
#302105   We used to do contract manufacturing of Methadone Chasing 10/19/18 02:23:59 PM
#302104   $3-4 Billion gets you: ---- a Multi-Billion NASDAQ2020 10/19/18 01:59:47 PM
#302103   Anybody in NYC next week? WeeZuhl 10/19/18 01:59:13 PM
#302102   one explanation would be that these smaller pharma toofun 10/19/18 01:37:26 PM
#302101   The current unexplained current EPIC/ELTP relationship is very imanjen13 10/19/18 01:27:50 PM
#302100   Thanks WeeZuhl, IB_ 10/19/18 01:05:31 PM
#302099   Nasrat best not pull Isradipine from Epic with WeeZuhl 10/19/18 12:58:34 PM
#302098  Restored Next Year Nasrat will have Big Pharma NASDAQ2020 10/19/18 12:48:23 PM
#302097   BP is truly threatened by ELTP being able mts 10/19/18 12:43:43 PM
#302096   I agree I Am very busy correcting the BS dr_lowenstein 10/19/18 12:28:18 PM
PostSubject